Duloxetine Starting Dose
The recommended starting dose of duloxetine for most adult patients is 30 mg once daily for 1 week, followed by an increase to the therapeutic dose of 60 mg once daily. 1, 2, 3
Standard Dosing Algorithm
Initial Week (Week 1)
- Start at 30 mg once daily to minimize nausea, which is the most common adverse effect causing treatment discontinuation 1, 4
- This lower starting dose allows patients to adjust to the medication before reaching therapeutic levels 1, 2
- The FDA label supports this approach, noting that "for some patients, it may be desirable to start at 30 mg once daily for 1 week" 3
Therapeutic Dose (Week 2 onwards)
- Increase to 60 mg once daily after the first week, which is the established therapeutic dose for most indications 1, 2
- This 60 mg daily dose is evidence-based for pain management across multiple conditions including diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain 2
Indication-Specific Considerations
Major Depressive Disorder
- The FDA label indicates a starting range of 40-60 mg/day (given as 20 mg twice daily or 30-60 mg once daily) 3
- However, the 30 mg × 1 week approach is preferred for tolerability 1
Diabetic Peripheral Neuropathy
- Standard dosing is 60 mg once daily 3
- For patients with tolerability concerns, start lower and titrate gradually 3
Chemotherapy-Induced Peripheral Neuropathy
- Use 30 mg daily for 1 week, then 60 mg daily 1
- Better response has been demonstrated in cisplatin-treated patients compared to taxane-treated patients 1
Fibromyalgia and Chronic Musculoskeletal Pain
- Begin at 30 mg once daily for 1 week, then increase to 60 mg once daily 1, 2
- Some patients may respond to the 30 mg starting dose, but 60 mg is the target therapeutic dose 3
Special Populations
Geriatric Patients (≥65 years)
- For generalized anxiety disorder, start at 30 mg once daily for 2 weeks before increasing to 60 mg 3
- Require slower titration compared to younger adults 2
Renal Impairment
- Consider a lower starting dose with gradual titration 2, 3
- Duloxetine is contraindicated in patients with creatinine clearance <30 mL/min 1, 4
Hepatic Impairment
Critical Tolerability Point
The 30 mg starting dose for 1 week significantly reduces treatment-emergent nausea while producing only a transient delay in therapeutic effect compared to starting at 60 mg daily. 1 This approach improves medication adherence by minimizing the most common reason for discontinuation 4.
Doses Above 60 mg Daily
- While 120 mg/day has been studied and shown to be effective, there is no evidence that doses greater than 60 mg/day confer additional benefits 3
- Higher doses are associated with increased adverse effects without improved efficacy 3, 5
- If increasing beyond 60 mg is considered, do so in 30 mg increments 3
Monitoring Requirements
- Assess for adverse effects at each follow-up visit, particularly nausea, dry mouth, dizziness, and somnolence 1, 4
- Monitor blood pressure as duloxetine can cause modest hypertension 1
- Unlike tricyclic antidepressants, duloxetine does not produce clinically important electrocardiographic changes 2, 4
- Routine aminotransferase monitoring is generally unnecessary 2